Cargando…

Higher proinflammatory responses possibly contributing to suppressed cytotoxicity in patients with COVID-19 associated mucormycosis

INTRODUCTION: COVID-19 Associated Mucormycosis (CAM), an opportunistic fungal infection, surged during the second wave of SARS Cov-2 pandemic. Since immune responses play an important role in controlling this infection in immunocompetent hosts, it is required to understand immune perturbations assoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Shete, Ashwini, Deshpande, Supriya, Sawant, Jyoti, Warthe, Nidhi, Thakar, Madhuri, Madkaikar, Manisha, Pradhan, Vandana, Rao, Prajwal, Rohatgi, Shalesh, Mukherjee, Aparna, Anand, Tanu, Satija, Aanchal, Sharma Velamuri, Poonam, Das, Madhuchhanda, Deasi, Nidhi, Kumar Tembhurne, Alok, Yadav, Reetika, Pawaskar, Swapnal, Rajguru, Chhaya, Sankhe, Lalitkumar R., Chavan, Shrinivas S., Panda, Samiran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier GmbH. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10089671/
https://www.ncbi.nlm.nih.gov/pubmed/37071959
http://dx.doi.org/10.1016/j.imbio.2023.152384
_version_ 1785022810241892352
author Shete, Ashwini
Deshpande, Supriya
Sawant, Jyoti
Warthe, Nidhi
Thakar, Madhuri
Madkaikar, Manisha
Pradhan, Vandana
Rao, Prajwal
Rohatgi, Shalesh
Mukherjee, Aparna
Anand, Tanu
Satija, Aanchal
Sharma Velamuri, Poonam
Das, Madhuchhanda
Deasi, Nidhi
Kumar Tembhurne, Alok
Yadav, Reetika
Pawaskar, Swapnal
Rajguru, Chhaya
Sankhe, Lalitkumar R.
Chavan, Shrinivas S.
Panda, Samiran
author_facet Shete, Ashwini
Deshpande, Supriya
Sawant, Jyoti
Warthe, Nidhi
Thakar, Madhuri
Madkaikar, Manisha
Pradhan, Vandana
Rao, Prajwal
Rohatgi, Shalesh
Mukherjee, Aparna
Anand, Tanu
Satija, Aanchal
Sharma Velamuri, Poonam
Das, Madhuchhanda
Deasi, Nidhi
Kumar Tembhurne, Alok
Yadav, Reetika
Pawaskar, Swapnal
Rajguru, Chhaya
Sankhe, Lalitkumar R.
Chavan, Shrinivas S.
Panda, Samiran
author_sort Shete, Ashwini
collection PubMed
description INTRODUCTION: COVID-19 Associated Mucormycosis (CAM), an opportunistic fungal infection, surged during the second wave of SARS Cov-2 pandemic. Since immune responses play an important role in controlling this infection in immunocompetent hosts, it is required to understand immune perturbations associated with this condition for devising immunotherapeutic strategies for its control. We conducted a study to determine different immune parameters altered in CAM cases as compared to COVID-19 patients without CAM. METHODOLOGY: Cytokine levels in serum samples of CAM cases (n = 29) and COVID-19 patients without CAM (n = 20) were determined using luminex assay. Flow cytometric assays were carried out in 20 CAM cases and 10 controls for determination of frequency of NK cells, DCs, phagocytes, T cells and their functionalities. The cytokine levels were analyzed for their association with each other as well as with T cell functionality. The immune parameters were also analyzed with respect to the known risk factors such as diabetes mellitus and steroid treatment. RESULTS: Significant reduction in frequencies of total and CD56 + CD16 + NK cells (cytotoxic subset) was noted in CAM cases. Degranulation responses indicative of cytotoxicity of T cell were significantly hampered in CAM cases as compared to the controls. Conversely, phagocytic functions showed no difference in CAM cases versus their controls except for migratory potential which was found to be enhanced in CAM cases. Levels of proinflammatory cytokines such as IFN-γ, IL-2, TNF-α, IL-17, IL-1β, IL-18 and MCP-1 were significantly elevated in cases as compared to the control with IFN-γ and IL-18 levels correlating negatively with CD4 T cell cytotoxicity. Steroid administration was associated with higher frequency of CD56 + CD16- NK cells (cytokine producing subset) and higher MCP-1 levels. Whereas diabetic participants had higher phagocytic and chemotactic potential and had higher levels of IL-6, IL-17 and MCP-1. CONCLUSION: CAM cases differed from the controls in terms of higher titers of proinflammatory cytokines, reduced frequency of total and cytotoxic CD56 + CD16 + NK cell. They also had reduced T cell cytotoxicity correlating inversely with IFN-γ and IL-18 levels, possibly indicating induction of negative feedback mechanisms while diabetes mellitus or steroid administration did not affect the responses negatively.
format Online
Article
Text
id pubmed-10089671
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier GmbH.
record_format MEDLINE/PubMed
spelling pubmed-100896712023-04-12 Higher proinflammatory responses possibly contributing to suppressed cytotoxicity in patients with COVID-19 associated mucormycosis Shete, Ashwini Deshpande, Supriya Sawant, Jyoti Warthe, Nidhi Thakar, Madhuri Madkaikar, Manisha Pradhan, Vandana Rao, Prajwal Rohatgi, Shalesh Mukherjee, Aparna Anand, Tanu Satija, Aanchal Sharma Velamuri, Poonam Das, Madhuchhanda Deasi, Nidhi Kumar Tembhurne, Alok Yadav, Reetika Pawaskar, Swapnal Rajguru, Chhaya Sankhe, Lalitkumar R. Chavan, Shrinivas S. Panda, Samiran Immunobiology Article INTRODUCTION: COVID-19 Associated Mucormycosis (CAM), an opportunistic fungal infection, surged during the second wave of SARS Cov-2 pandemic. Since immune responses play an important role in controlling this infection in immunocompetent hosts, it is required to understand immune perturbations associated with this condition for devising immunotherapeutic strategies for its control. We conducted a study to determine different immune parameters altered in CAM cases as compared to COVID-19 patients without CAM. METHODOLOGY: Cytokine levels in serum samples of CAM cases (n = 29) and COVID-19 patients without CAM (n = 20) were determined using luminex assay. Flow cytometric assays were carried out in 20 CAM cases and 10 controls for determination of frequency of NK cells, DCs, phagocytes, T cells and their functionalities. The cytokine levels were analyzed for their association with each other as well as with T cell functionality. The immune parameters were also analyzed with respect to the known risk factors such as diabetes mellitus and steroid treatment. RESULTS: Significant reduction in frequencies of total and CD56 + CD16 + NK cells (cytotoxic subset) was noted in CAM cases. Degranulation responses indicative of cytotoxicity of T cell were significantly hampered in CAM cases as compared to the controls. Conversely, phagocytic functions showed no difference in CAM cases versus their controls except for migratory potential which was found to be enhanced in CAM cases. Levels of proinflammatory cytokines such as IFN-γ, IL-2, TNF-α, IL-17, IL-1β, IL-18 and MCP-1 were significantly elevated in cases as compared to the control with IFN-γ and IL-18 levels correlating negatively with CD4 T cell cytotoxicity. Steroid administration was associated with higher frequency of CD56 + CD16- NK cells (cytokine producing subset) and higher MCP-1 levels. Whereas diabetic participants had higher phagocytic and chemotactic potential and had higher levels of IL-6, IL-17 and MCP-1. CONCLUSION: CAM cases differed from the controls in terms of higher titers of proinflammatory cytokines, reduced frequency of total and cytotoxic CD56 + CD16 + NK cell. They also had reduced T cell cytotoxicity correlating inversely with IFN-γ and IL-18 levels, possibly indicating induction of negative feedback mechanisms while diabetes mellitus or steroid administration did not affect the responses negatively. Elsevier GmbH. 2023-05 2023-04-11 /pmc/articles/PMC10089671/ /pubmed/37071959 http://dx.doi.org/10.1016/j.imbio.2023.152384 Text en © 2023 Elsevier GmbH. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Shete, Ashwini
Deshpande, Supriya
Sawant, Jyoti
Warthe, Nidhi
Thakar, Madhuri
Madkaikar, Manisha
Pradhan, Vandana
Rao, Prajwal
Rohatgi, Shalesh
Mukherjee, Aparna
Anand, Tanu
Satija, Aanchal
Sharma Velamuri, Poonam
Das, Madhuchhanda
Deasi, Nidhi
Kumar Tembhurne, Alok
Yadav, Reetika
Pawaskar, Swapnal
Rajguru, Chhaya
Sankhe, Lalitkumar R.
Chavan, Shrinivas S.
Panda, Samiran
Higher proinflammatory responses possibly contributing to suppressed cytotoxicity in patients with COVID-19 associated mucormycosis
title Higher proinflammatory responses possibly contributing to suppressed cytotoxicity in patients with COVID-19 associated mucormycosis
title_full Higher proinflammatory responses possibly contributing to suppressed cytotoxicity in patients with COVID-19 associated mucormycosis
title_fullStr Higher proinflammatory responses possibly contributing to suppressed cytotoxicity in patients with COVID-19 associated mucormycosis
title_full_unstemmed Higher proinflammatory responses possibly contributing to suppressed cytotoxicity in patients with COVID-19 associated mucormycosis
title_short Higher proinflammatory responses possibly contributing to suppressed cytotoxicity in patients with COVID-19 associated mucormycosis
title_sort higher proinflammatory responses possibly contributing to suppressed cytotoxicity in patients with covid-19 associated mucormycosis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10089671/
https://www.ncbi.nlm.nih.gov/pubmed/37071959
http://dx.doi.org/10.1016/j.imbio.2023.152384
work_keys_str_mv AT sheteashwini higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis
AT deshpandesupriya higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis
AT sawantjyoti higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis
AT warthenidhi higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis
AT thakarmadhuri higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis
AT madkaikarmanisha higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis
AT pradhanvandana higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis
AT raoprajwal higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis
AT rohatgishalesh higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis
AT mukherjeeaparna higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis
AT anandtanu higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis
AT satijaaanchal higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis
AT sharmavelamuripoonam higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis
AT dasmadhuchhanda higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis
AT deasinidhi higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis
AT kumartembhurnealok higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis
AT yadavreetika higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis
AT pawaskarswapnal higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis
AT rajguruchhaya higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis
AT sankhelalitkumarr higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis
AT chavanshrinivass higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis
AT pandasamiran higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis